ENSG00000014216 Expression In 33 Tumors
| Ensembl ID |
Gene symbol |
Log2 Foldchange |
Pvaue |
Cancer |
| ENSG00000014216 |
|
0.51 |
1.11e-19 |
BRCA |
| ENSG00000014216 |
|
0.81 |
1.48e-22 |
LUSC |
| ENSG00000014216 |
|
-0.3 |
1.99e-11 |
PRAD |
| ENSG00000014216 |
|
0.71 |
1.36e-13 |
KIRP |
| Ensembl ID |
Gene symbol |
Cancer types |
Pubmed ID |
| ENSG00000014216 |
|
TGCT |
17711579 |
| ENSG00000014216 |
|
tumor |
25927284 |
| ENSG00000014216 |
|
acute myeloid leukemia (AML) |
27294874 |
| ENSG00000014216 |
|
breast cancer |
27402795 |
| ENSG00000014216 |
|
laryngeal cancer |
27456359 |
| ENSG00000014216 |
|
tumor |
2999095 |
| ENSG00000014216 |
|
tumor |
30030436 |
| ENSG00000014216 |
|
tumor |
30131853 |
| ENSG00000014216 |
|
tumor |
30390003 |
| ENSG00000014216 |
|
tumor |
30863494 |
| Ensembl ID |
Gene symbol |
Disease/phenotype |
Mutation type |
Mutated / Total samples |
Literature |
| Ensembl ID |
Gene symbol |
Cancer |
P-value |
Which worse |
show |
| ENSG00000014216 |
|
MESO |
0.027 |
low |
|
| ENSG00000014216 |
|
SARC |
0.0026 |
low |
|
| ENSG00000014216 |
|
STAD |
0.0071 |
low |
|
| ENSG00000014216 |
|
CHOL |
0.0095 |
low |
|
| ENSG00000014216 |
|
PAAD |
0.00048 |
high |
|
| ENSG00000014216 |
|
ACC |
0.018 |
low |
|
| ENSG00000014216 |
|
READ |
0.043 |
low |
|
| ENSG00000014216 |
|
KIRP |
0.00024 |
low |
|
| ENSG00000014216 |
|
LUAD |
0.011 |
high |
|
| ENSG00000014216 |
|
THYM |
0.001 |
high |
|
| ENSG00000014216 |
|
ESCA |
0.027 |
low |
|
| ENSG00000014216 |
|
OV |
0.017 |
high |
|
| ENSG00000014216 |
|
DLBC |
0.044 |
high |
|
| ENSG00000014216 |
|
KIRC |
0.00017 |
low |
|
| ENSG00000014216 |
|
LAML |
0.00013 |
high |
|
| ENSG00000014216 |
|
GBM |
0.022 |
high |
|
| ENSG00000014216 |
|
LIHC |
0.00047 |
high |
|
| Ensembl ID |
Gene symbol |
Cancer |
CNV type |
-log10(q-value) |
G-score |
average amplitude |
frequency |
| ENSG00000014216 |
|
SKCM |
Del |
0.941250 |
0.070505 |
0.446056 |
0.354223 |
| ENSG00000014216 |
|
BRCA |
Del |
4.914250 |
0.092226 |
0.439424 |
0.225000 |